a Background: Current service delivery systems do not reach all people in need of antiretroviral therapy (ART). In order to inform the operational and service delivery section of the WHO 2013 consolidated antiretroviral guidelines, our objective was to summarize systematic reviews on integrating ART delivery into maternal, newborn, and child health (MNCH) care settings in countries with generalized epidemics, tuberculosis (TB) treatment settings in which the burden of HIV and TB is high, and settings providing opiate substitution therapy (OST); and decentralizing ART into primary health facilities and communities.
Introduction
Global efforts to scale up antiretroviral therapy (ART) between 2002 and 2012 averted an estimated 4.2 million deaths in low-income and middle-income countries [1] . The United Nations endorsed the importance of this impact and agreed to scale up ART to 15 million people by 2015 [2] . In 2012, 9.7 million (65% of the global target) were receiving ART [1] . Antiretroviral therapy also has an important impact on HIV transmission [3] [4] [5] . Accelerating population impact will require adaptations in the delivery of HIV care and treatment tailored to epidemiological, social, and health systems context.
Provider-initiated HIV testing and counselling is recommended in all patients with presumptive and diagnosed tuberculosis (TB) [6] and in all maternal, newborn, and child health (MNCH) care settings in generalized epidemics [7] . WHO also recommends HIV testing and counselling to all people attending drug dependence treatment services as part of a comprehensive package of services [7, 8] . Provider-initiated testing and counselling should also be considered in primary health facilities where epidemiologically appropriate [7] . Despite these recommendations, in 2012, 57% of people with HIV and active TB received ART [9] , 59% of eligible pregnant women received ART [1] , and the available data suggest that 1-22% of people with HIV who inject drugs in high-burden countries received ART [10, 11] . Coverage in all three of these populations remained lower than the coverage achieved among all adults with HIV [1] . Integrating ART into TB, MNCH, and opiate substitution therapy (OST) care settings and decentralizing ART to primary care health facilities, where populations are already receiving testing and counselling, may increase accessibility, affordability, and acceptability of HIV services. This could also change the paradigm of national programming in some settings from being vertical, where only HIV health facilities are used for delivering HIV services, to diagonal, wherein sound HIV testing, care, and treatment are integrated into strong health systems [12] .
Earlier reviews have covered decentralization [13] , community-based ART [14] , and models of HIV integration with TB care [15, 16] , MNCH services [17, 18] , and OST [19] . Our objective was to summarize the findings of several systematic reviews conducted for the 2013 WHO consolidated antiretroviral guidelines on HIV service integration and decentralization.
Methods
Conduct of systematic reviews Systematic reviews were conducted to inform HIV service delivery and operational recommendations as part of the 2013 WHO guidelines preparation [20] . For the reviews on integration and decentralization of ART 
Study definitions
Integrated ART was defined as providing ART at MNCH, TB, or OST health facilities. Separate ART was defined as providing ART and MNCH, TB, or OST services at multiple health facilities. Partial decentralization was defined as initiation at hospitals and maintenance at primary health facilities, full decentralization was defined as initiation and maintenance at primary health facilities, and community-based ART was defined as initiation at either a hospital or primary health facility with maintenance between facility visits through community-based approaches (e.g., home-based delivery or utilizing networks of people with HIV). MNCH facilities were defined as those providing antenatal, postnatal, infant, and/or child health services. Primary health facilities provided care for multiple diseases and were sometimes called primary health centers or primary health clinics. TB treatment settings included a range of health sites providing tuberculosis treatment (e.g. TB facilities, primary health facilities, and hospitals). Antiretroviral therapy coverage was defined as the number of persons who initiated ART divided by the number of people who were eligible per national clinical guidelines. Retention in care was defined as the number of people who remained in care after a time period, selfdefined by studies, divided by the number of people who enrolled in care. Mortality was defined as the number of people who are enrolled in care and died of any cause divided by the number of people enrolled in care.
Selection criteria
Two reviewers independently screened abstracts of all identified articles and examined the full text articles of those that seemed relevant. Studies meeting each review's respective eligibility criteria were included. For service integration, studies were included when the study population included people with HIV; the intervention was ART integrated into MNCH care where there is a generalized HIV epidemic, settings providing TB treatment where there is a high burden of HIV and TB, or settings providing OST; the comparator was separate services; the outcomes were mortality, retention in HIV care, and/or ART coverage; and the study design was a randomized trial or an observational cohort study.
The decentralization review's eligibility criteria included the same population, outcomes, and study designs. The reviewers included studies with partial decentralization, full decentralization, and community-based ART as the intervention and hospital-based ART as the comparator after one year of ART.
Statistical analyses
Studies meeting eligibility criteria were stratified by service delivery approach (i.e., MNCH integration, TB integration, OST integration, partial decentralization, full decentralization, or community-based ART). As proportions were used to gauge ART coverage, retention, and mortality, the frequency of events was quantified using risks, and relative risks (RRs) were used for comparisons. Pooled RRs were used, when appropriate, to compare participants in the intervention and comparator arms of multiple studies meeting eligibility criteria. Random-effects models were used for all metaanalyses. I-squared statistics were used to measure heterogeneity [21] . I-squared statistics near 25% indicate low heterogeneity, values near 50% indicate moderate heterogeneity, and those above 75% indicate high heterogeneity [22] . Analyses were completed in STATA version 12.0 and Review Manager version 5.1.
Results
Antiretroviral therapy integration with maternal, neonatal, and child healthcare services Nine hundred forty-nine studies were screened and four met the inclusion criteria ( Fig. 1a and Table 1 ). None of the studies evaluated mortality. One study evaluated retention in care and found similar rates among pregnant and breastfeeding women in integrated versus separate services [23] (Fig. 2) . Four studies evaluated ART coverage. Three studies reported improved coverage in integrated services [23] [24] [25] and one study reported similar coverage [26] (Fig. 2) . Overall, there was an improvement in ART coverage across all four studies (RR 1.37, 95% confidence interval [CI] 1.05-1.79, Fig. 3 ).
Antiretroviral therapy integration with tuberculosis treatment services
One thousand one hundred sixty-four studies were screened and twelve studies met the inclusion criteria ( Fig. 1b and Table 1 ). None of the studies evaluated retention. Twelve studies evaluated ART coverage. Nine [27] [28] [29] [30] [31] [32] [33] [34] [35] reported improved coverage, and three [36] [37] [38] reported similar coverage, when ARTwas provided in TB care settings versus separate services (Fig. 2) . Overall, there was an improvement in ART coverage across all twelve studies (RR 1.83, 95% CI 1.48-2.25, Fig. 3 ). Four studies evaluated mortality. Two studies [30, 35] reported reduced mortality and two studies reported similar mortality [37, 38] when ART was provided in TB care settings compared with separate services (Fig. 2) . Overall, rates of mortality were nonsignificantly reduced in integrated versus separate services (RR 0.55, 95% CI 0.29-1.05).
Antiretroviral therapy integration with services providing opiate substitution therapy Four hundred eight studies were screened and two met the inclusion criteria ( Fig. 1c and Table 1 ). One study evaluated ART coverage. This study reported similar ART coverage when ART was provided in OST settings compared with separate ART and OST care settings (Figs 2 and 3) [39] . One study evaluated retention and mortality, and showed similar retention and mortality in integrated versus separate services [40] (Fig. 2 ).
Partial decentralization of antiretroviral therapy
Three thousand four hundred thirty-seven studies were screened and four met the inclusion criteria ( Fig. 1d and Table 1 ). None of the studies evaluated ART coverage. Three studies reported improved retention in care [41] [42] [43] , and one study reported similar retention [44] (Fig. 4) . Overall, there was improved retention across all four studies (RR 1.05, 95% CI 1.01-1.09, Fig. 5 ). All studies reported reduced mortality [41] [42] [43] [44] (overall RR 0.34, 95% CI 0.13-0.87) (Fig. 4 ).
Full decentralization of antiretroviral therapy
Three thousand four hundred thirty-seven studies were screened and four studies met the inclusion criteria ( Fig. 1d and Table 1 ). None of the studies evaluated ART coverage. All studies reported improved retention in care [45] [46] [47] [48] (overall estimate RR 1.12, 95% CI 1.08-1.17, Figs 4 and 5). Three studies reported reduced mortality [46] [47] [48] , although one estimate lacked statistical significance [47] , whereas one study reported increased mortality [45] (Fig. 4) . Overall, the rates of mortality were comparable in fully decentralized and hospital-based ART (RR 1.10, 95% CI 0.63-1.92).
Community-based antiretroviral therapy
Three thousand four hundred thirty-seven studies were screened and two studies met the inclusion criteria ( Fig. 1d and Table 1 ). Neither evaluated ART coverage. Both reported similar retention [49, 50] (overall RR 1.01, 95% CI 0.99-1.03, Figs 4 and 5). Both reported similar mortality [49, 50] (overall RR 1.03, 95% CI 0.64-1.65) (Fig. 4) . The reported relative risk in this study was comparing integrated HIV services overall to vertical services. The intervention was providing ART at the same health facility.
Discussion
In many cases, there were improvements in ART coverage and reductions in mortality with service integration and improvements in retention and reductions in mortality with decentralization. There were no adverse outcomes associated with integrating ART into other programmes, decentralizing ART into primary health facilities, and providing community-based ART between facility visits. This may be associated with the availability of the full range of HIV services (i.e., HIV testing and counselling, HIV care, and ART) at a single site. There were limited data on the acceptability and quality of services. Researchers and countries should continue monitoring integration and decentralization efforts closely to ensure the quality of services is not adversely affected. Ensuring timely access to comprehensive and evidence-based interventions is also necessary for improved health outcomes. This should include both HIV and non-HIV services that are essential for the general population, pregnant and breastfeeding women, persons with TB, and people who inject drugs.
Based on these data, programme risks and benefits, acceptability; values; and preferences, cost implications, feasibility and critical contextual constraints, and contextual relevance, the 2013 WHO consolidated antiretroviral guidelines recommend:
(1) In generalized epidemic settings, ART should be initiated and maintained in eligible pregnant and postpartum women and in infants at MNCH care settings, with linkage and referral to ongoing HIV care and ART, wherever appropriate. HIV service integration and decentralization Suthar et al. S181 Pooled relative risk for retention in care
Partial decentralization
Model of decentralisation (a) initiation of ART in hospitals with maintenance of ART in peripheral health facilities, (b) initiation and maintenance of ART in peripheral health facilities, (c) initiation of ART at peripheral health facilities with maintenance at the community level (i.e., outside health facilities in settings such as outreach sites, health posts, home-based services, or communitybased organizations) between regular clinical visits.
There are a number of factors that programmes will need to consider when expanding access to ART through integration and decentralization within their unique context. These include the volume of people with HIV expected in integrated and decentralized sites, whether integration and decentralization of ART brings services closer to people who otherwise must travel long distances to receive HIV care and treatment, whether integration and decentralization of HIV treatment reduces workload to overburdened health facilities, and whether integration and decentralization of HIV treatment improves access for populations who often face stigma, discrimination, and criminalization. Evaluation of these factors may help programmes when prioritizing integration and decentralization efforts and facilitate scale-up based on experiences and lessons learned.
Creating an enabling and collaborative programme and policy environment is critical for success in service delivery. This includes mechanisms for joint planning, monitoring and evaluation, resource mobilization, programme supervision and review, and health worker training and mentoring. MNCH, TB, and OST services are entry points for lifelong care for people diagnosed with HIV in such settings, and these services will need to ensure continuity of care. Some MNCH care settings may opt to refer women and children to HIV clinics after completion of childhood immunizations, cessation of breastfeeding, or the child's definitive HIV diagnosis. Other MNCH care settings may decide to provide family-focused ART services. TB and HIV programmes will also need to assess whether referral of people with HIV at completion of TB treatment or providing lifelong ART at TB care settings is locally feasible. Given that OST often requires long-term care referral after OST completion may need evaluation based on patient preferences and local feasibility.
A 2011 WHO survey indicated that the ratio of TB treatment facilities to HIV facilities providing ART was 1.3 in South Africa, 2.6 in Zimbabwe, 5.8 in Mozambique, 8.9 in Nigeria, and 30.4 in India [51] . This suggests that many countries with high burdens of HIV and TB may have opportunities to expand access to ART to people with HIV and active TB by integrating services. However, countries will also need to evaluate epidemiological burden to understand where integration offers advantages. For example, rather than integrating services nationwide, integration may make the most sense in settings where the burden of HIV and TB is high. These considerations also apply to integration of ART into MNCH care in generalized epidemic settings and the decentralization of ART into primary health facilities [52] . In all healthcare settings routine implementation of TB infection control measures is vital to reduce risk of nosocomial TB transmission [53] .
WHO recommends a comprehensive package of interventions for the prevention, treatment, and care of HIV among people who inject drugs, including needle and syringe programmes; OST and other evidence-based drug dependence treatment; HIV testing and counselling; ART; prevention and treatment of sexually transmitted infections; condom distribution programmes for people who inject drugs and their sexual partners; targeted information, education and communication for people who inject drugs and their sexual partners; prevention, vaccination, diagnosis, and treatment for viral hepatitis; and prevention, diagnosis, and treatment of TB [8] . In many settings with a large number of people who inject drugs, there remains limited access to OST, with provision often being led by community-based and nongovernmental organizations [11] . Therefore, HIV programmes may need to collaborate with these organizations when integrating services. OST has considerable benefits for people who inject drugs, including reducing opioid and other drug use, criminal activity, risk behaviours, opioid overdose, and all-cause mortality [54] . These benefits can also support adherence to ART and improve rates of viral suppression [40] .
There are some shared implementation considerations for integrating and decentralizing HIV services. First, HIV programmes need to strengthen supply chain management systems to prevent stock outs of antiretroviral drugs and other key commodities [55] . Second, HIV programmes may consider a phased approach for integrating and decentralizing ART to strengthen supply management systems, service organization at the facility level, and monitoring and evaluation systems. Third, decentralized and integrated delivery of ART in many settings implies initiation and maintenance of HIV care and treatment by trained nonspecialized healthcare providers, nurses, and nonphysician clinicians. In order to prevent overburdening nonphysician clinicians, some tasks may also need to be shifted to or shared with trained community health workers and 'lay providers'. Randomized trials have examined the risks and benefits of task shifting and sharing for both initiation [56] and maintenance [50, 56, 57] of ART by nurses and nonphysician clinicians. Based on these trials and observational studies [20] , WHO recommends that trained nonphysician clinicians, nurses, and midwives can initiate first-line ART and maintain ART, and that community health workers can dispense ART between facility visits [58] . Effective task shifting and sharing requires providing training, mentoring, and supportive supervision for all healthcare providers; ensuring clear criteria for when, where, and to whom patients should be referred when necessary; implementing standardized monitoring and evaluation systems across all health facilities providing HIV care; and ensuring quality care in all settings providing HIV care.
TB, MNCH, and OST were reviewed due to programme synergies; however, future research should evaluate the potential for ART integration in settings providing treatment for STIs and immunizations. Antiretroviral therapy in STI treatment settings could expand access to sex workers and men who have sex with men, whereas ART in settings providing immunizations could expand access to the paediatric population. Most identified studies had limited periods of follow-up. The feasibility, sustainability, and retention of people with HIV may be different over longer periods of time, and studies are needed to understand integration and decentralization outcomes fully. It is difficult to ascertain the benefits and risks of integrating ART into OST settings, as there is potential for confounding owing to differences in access to OST [59, 60] and directly observed ART [61, 62] . Future research could provide improved estimates.
Using the I-squared statistic, there was high heterogeneity for most of the meta-analyses. All analyses should be interpreted with respect to local epidemiology, social and cultural context, and health systems organization of studies contributing data. Moreover, there were limited data on patient and health worker acceptability of integrating and decentralizing services. For MNCH, some data suggested that providers and patients had positive perspectives and experiences with service integration [63, 64] . Qualitative research is needed to further understand the effects of service integration and decentralization on stigma and normalization of HIV services, particularly in providing services to key populations (i.e. men who have sex with men, sex workers, people who inject drugs, and transgender people). Finally, the overall implications of service integration on the health system, including on health workers skill mix, workload, and 'scope of practice', will need to be documented to further strengthen learning from programme implementation.
In conclusion, service integration was often associated with improved ART coverage, whereas decentralization often improved retention. Neither integration nor decentralization was associated with harmful outcomes. Many studies indicated reduced mortality for integration and decentralization and these estimates could be improved by additional studies following people longer. Implementation research is also needed to establish estimates in different geographical and sociocultural contexts. As countries develop their new national strategic plans and investment cases, consideration should be given to expanding access to ART through integration and decentralization [58] .
